Free from Publisher

Embolic agent choice in middle meningeal artery embolization as primary or adjunct treatment for chronic subdural hematoma: a systematic review and meta-analysis

JC Ku, MA Essibayi, MA Banihashemi… - American Journal …, 2023 - Am Soc Neuroradiology
BACKGROUND: Middle meningeal artery embolization is an emerging treatment option for
chronic subdural hematomas. PURPOSE: Our aim was to assess outcomes following middle …
被引用次数：25 相关文章

Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct Treatment for Chronic Subdural Hematoma: A Systematic Review and Meta …

JC Ku, AA Dmytriw, MA Essibayi… - … . American Journal of …, 2023 - europepmc.org
Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct
Treatment for Chronic Subdural Hematoma: A Systematic Review and Meta-analysis. - Abstract …

Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct Treatment for Chronic Subdural Hematoma: A Systematic Review and Meta …

JC Ku, AA Dmytriw, MA Essibayi… - FRED™ …, 2023 - Am Soc Neuroradiology
ABSTRACT BACKGROUND: Middle meningeal artery embolization is an emerging
treatment option for chronic subdural hematomas. PURPOSE: Our aim was to assess …

Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct Treatment for Chronic Subdural Hematoma: A Systematic Review and Meta …

JC Ku, AA Dmytriw, MA Essibayi… - American Journal …, 2023 - einstein.elsevierpure.com
BACKGROUND: Middle meningeal artery embolization is an emerging treatment option for
chronic subdural hematomas. PURPOSE: Our aim was to assess outcomes following middle …
[HTML] nih.gov

[HTML][HTML] Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct Treatment for Chronic Subdural Hematoma: A Systematic Review and …

JC Ku, AA Dmytriw, MA Essibayi… - … : American Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND: Middle meningeal artery embolization is an emerging treatment option for
chronic subdural hematomas. PURPOSE: Our aim was to assess outcomes following middle …

Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct Treatment for Chronic Subdural Hematoma: A Systematic Review and Meta …

JC Ku, AA Dmytriw, MA Essibayi… - AJNR. American …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Middle meningeal artery embolization is an emerging treatment option for
chronic subdural hematomas. Purpose Our aim was to assess outcomes following middle …

Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct Treatment for Chronic Subdural Hematoma: A Systematic Review and Meta …

JC Ku, AA Dmytriw, MA Essibayi… - … . American Journal of …, 2023 - europepmc.org
Middle meningeal artery embolization is an emerging treatment option for chronic subdural
hematomas. Our aim was to assess outcomes following middle meningeal artery …